PAR 2.04% 25.0¢ paradigm biopharmaceuticals limited..

Motor neuron disease (MND) and inflammation

  1. 45 Posts.
    lightbulb Created with Sketch. 11
    Mozzarc read you comment about inflammatory addressable conditions

    Unfortunately I have a friend recently diagnosed with advanced MND and thought could iPPS help them in any way and found the below. Not sure if its been covered in other threads but another opportunity for Paradigm to help people in need.

    Motor neuron disease (MND) is a progressive condition that occurs when certain nerve cells degenerate and die. There are two types of motor neuron cells. The upper motor neuron begins in the brain and ends in the spinal cord. The lower motor neuron starts in the spinal cord and ends in the muscles. Now researchers from Melbourne are working to develop a potential treatment to slow the progression of MND, by taking the “sting” out of it, literally. By blocking an immune sensor called STING, the researchers were able to prevent inflammation from MND patient cells in mouse models. Their findings may open a new door of drug development for those with MND and neurodegenerative disorders.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.5¢ $8.544K 34.18K

Buyers (Bids)

No. Vol. Price($)
1 6128 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 1500 1
View Market Depth
Last trade - 10.29am 01/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.